药物信息为DARAPRIM (pyrimethamine) 25-mg Scored Tablets (GlaxoSmithKline): ADVERSE REACTIONS
- CLINICAL PHARMACOLOGY
- ADVERSE REACTIONS
- HOW SUPPLIED
- Diseases/Conditions Related to DARAPRIM (pyrimethamine) 25-mg Scored Tablets (GlaxoSmithKline)
- 外部链接相关的DARAPRIM (pyrimethamine) 25-mg Scored Tablets (GlaxoSmithKline)
Hypersensitivity reactions, occasionally severe (such as Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema multiforme, and anaphylaxis), and hyperphenylalaninemia, can occur particularly when pyrimethamine is administered concomitantly with a sulfonamide. Consult the complete prescribing information for the relevant sulfonamide for sulfonamide-associated adverse events. With doses of pyrimethamine used for the treatment of toxoplasmosis, anorexia and vomiting may occur. Vomiting may be minimized by giving the medication with meals; it usually disappears promptly upon reduction of dosage. Doses used in toxoplasmosis may produce megaloblastic anemia, leukopenia, thrombocytopenia, pancytopenia, atrophic glossitis, hematuria, and disorders of cardiac rhythm. Hematologic effects, however, may also occur at low doses in certain individuals (see PRECAUTIONS: General).
Pulmonary eosinophilia has been reported rarely.
- Drug Information Provided by National Library of Medicine (NLM).